ALLERGIKA GmbH
Transcription
ALLERGIKA GmbH COMPANY PRESENTATION Year 2012 ALLERGIKA GmbH, Bürgermeister-Seidl-Str. 8, 82515 Wolfratshausen / Germany www.allergika.de CONTENTS COMPANY PROFILE COMPANY PROFILE ALLERGIKA GmbH was founded as ILLA Healthcare GmbH in 1991 ALLERGIKA® dermocosmetics have been launched in 2008 Foundation 1991 as ILLA Healthcare GmbH 2009 change of the company name to ALLERGIKA GmbH Shareholder Hartmut Bannert Employees approx. 30 COMPANY PROFILE ALLERGIKA – Success in allergy prevention and treatment for nearly 20 years 1991 Foundation as ILLA Healthcare GmbH 1995 Launch ALLERGIKA® Anti-dust mite covers 2008 Launch ALLERGIKA® dermocosmetics in Germany and Austria 2010 ALLERGIKA® trademark registration in over 50 countries 2011 Launch ALLERGIKA® dermocosmetics in Hungary & Andorra 2011 Distribution Agreement (dermocosmetics) signed with Luxembourg (Launch March 2012) 2012 Launch of Allergika dermocosmetics & textiles in Hong Kong 2012 Other export negotiations started in many countries (dermocosmetic & textile) COMPANY PROFILE The name ALLERGIKA® represents the unique ALLERGIKA® product and marketing concept and stands for an unique concept for 30% of the population ALLERGIKA® Company name ALLERGIKA® Umbrella trademark ALLERGIKA® Products, indications and applications ALLERGIKA® Identification of patients ALLERGIKA® Doctors, pharmacists and customers identify ALLERGIKA as a company specialised in allergies COMPANY PROFILE ALLERGIKA® is organized in two business units ALLERGIKA® Hair Care ALLERGIKA® Facial Care ALLERGIKA® Hand Care 8 Medical Concepts ALLERGIKA® Body care ALLERGIKA® Atopic skin ALLERGIKA® Babies & kids ALLERGIKA® Sun protection ALLERGIKA® Foot care (to be launched in 2012) Business Unit DERMA: Business Unit TEXTILE ALLERGIKA® Encasings (Anti dust mite covers) ALLERGIKA® Travel ALLERGIKA® Dust mite test ALLERGIKA® Dust mite acaricide Dermifant® Neurodermatitis overalls CONTENTS PRODUCT PORTFOLIO BUSINESS UNIT DERMA ALLERGIKA PRODUCTION & QUALITY STANDARDS ALLERGIKA® dermocosmetics are consequently produced: without perfumes without preservatives without colorants without natural allergenes without other allergenes listed by the German Contact Dermatitis Group GMP pharmaceutical manufacture Patented, airless medical packaging Each product was tested on allergic skin with best results ! Certified by ALLERGIKA – 8 Dermocosmetic concepts ALLERGIKA® offers the only medical dermocosmetic concept tailormade for allergic patients from top to toe with special products for atopic & dry skin, contact dermatitis & sun allergy. 1) Sun protection 2) Hair care 3) Facial care 4) Hand protection 5) Body care 6) Atopic, irritated & sensitive skin care 8) Skin care for kids and babies 7) Foot care (2012) 1) Sun Protection 2) Hair Care 3) Facial Care 4) Hand Protection 5) Dry skin care 5) Dry skin care 6) Atopic, irritated & sensitive skin care 7) Foot Care 8) Skin care for kids & babies CONTENTS ALLERGY MARKET ALLERGY MARKET 1. Over 30% of the population of all industrial countries are affected by allergic diseases with an rising incidence. 2. 30% of all allergic patients suffer from skin diseases (10% of the population). The main symptoms: Inflammation, dry and itching skin. 10% with skin diseases! ALLERGY MARKET Inheritance of atopic diseases: Parents pass atopic diseases on to their children with a risk of 70% ! This the reason why ALLERGIKA® offers a full range of dermocosmetics including a special skin care for babies & kids from day one (-> ALLERGIKA® Dermifant, see page 17) One parent is atopic Both parents are atopic Both parents are atopic with the same symptoms ALLERGY MARKET Relevant indications for ALLERGIKA® dermocosmetics: Range Indication EU-Market (%) 1 Itching, sensitive and irritating skin 50%* 2 Dry skin 30%** 3 Pollen allergy (itching eyes) 20%** 4 Sun allergy, Skin cancer, Sun defects 20%** 5 Eczema & Atopic dermatitis 10%** 6 Contact dermatitis 5%*** 7 New born babies (sensitive, dry skin) 1%** *Caress et al., J. Envir. Health 3/2009; Thyssen et al. Br. J. Dermat. 160, 2009 **Charité Berlin and WHO 2005 ***IVDK e.V., Göttingen CONTENTS STRATEGY MARKETING STRATEGY ALLERGIKA® dermocosmetics are positioned as the only skin care concept for damaged skin without natural and chemical allergens Allergens based on natural substances Natural cosmetics for wellness and beauty like Weleda, Lavera Damaged skin Healthy skin Common dermocosmetics like Louis Widmer, Avene, La Roche-Posay, Eucerin Common cosmetics for wellness and beauty like Vichy Allergens based on chemical substances STRATEGIC OBJECTIVES The ideal marketing partner has the following profile: Pharmaceutical company with dermatological and/or dermocosmetic and/or OTC business. Sales force for dermatologists, eventual pediatricians and pharmacies. Sales force activities to hospitals are a plus. ALLERGIKA® dermocosmetics are complementary to the existing product portfolio. Enthusiasm about the ALLERGIKA® dermocosmetic concept. STRATEGIC OBJECTIVES ALLERGIKA® offers long-term marketing partnerships Exclusive marketing rights Use of the trademark „ALLERGIKA®“ Product packaging in native language Marketing and promotional support International awareness Thank you very much for your attention! Questions?
Similar documents
Latest Report of Atopic Dermatitis Global Clinical - Classification, Prevention, Treatment and Symptoms
Atopic dermatitis is a common inflammatory skin condition characterized by relapsing eczematous lesions in a typical distribution. It can be frustrating for pediatric patients, parents, and health care providers alike. The pediatrician will treat the majority of children with atopic dermatitis as many patients will not have access to a pediatric medical subspecialist, such as a pediatric dermatologist or pediatric allergist. Atopic Dermatitis Global Clinical report provides up-to-date information regarding the disease and its impact, pathogenesis, treatment options, and potential complications. The goal of this report is to assist pediatricians with accurate and useful information that will improve the care of patients with atopic dermatitis.
More information